Cargando…
Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes
Patients with cancer demonstrate particularly poor outcomes from COVID-19. To provide information essential for understanding the biologic underpinnings of this association, we analyzed whole-transcriptome RNA expression data obtained from a large cohort of cancer patients to characterize expression...
Autores principales: | Elliott, Andrew, Saul, Michelle, Zeng, Jia, Marshall, John L., Kim, Edward S., Nagasaka, Misako, Lenz, Heinz-Josef, Schwartzberg, Lee, Spetzler, David, Abraham, Jim, Xiu, Joanne, Stafford, Phillip, Michael Korn, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952699/ https://www.ncbi.nlm.nih.gov/pubmed/33707526 http://dx.doi.org/10.1038/s41598-021-84731-7 |
Ejemplares similares
-
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing
por: Nagasaka, Misako, et al.
Publicado: (2023) -
Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
por: Feng, Huan, et al.
Publicado: (2020) -
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset
por: Nagasaka, Misako, et al.
Publicado: (2023) -
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
por: Abraham, Jim, et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)